Annual SG&A
$0.00$687.44M-100.00%
Summary
- Current Value
- As of today, ROIV annual SG&A is $0.00, down -100.00% on
- Historical Performance
- ROIV annual SG&A is down -100.00% over the past 3 years, and down -100.00% over the past 5 years
- All-Time High Comparison
- ROIV annual SG&A is currently -100.00% below its historical high of $775.03M set on
- 3-Year Low Comparison
- ROIV annual SG&A vs 3-year low value is unknown
- Sector Comparison
- ROIV annual SG&A is higher than 39.46% of companies in Healthcare sector
SG&A Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual SG&A | $0.00 | -100.0% | -100.0% | -100.0% | -100.0% | |
| Quarterly SG&A | $0.00 | -100.0% | -100.0% | -100.0% | -100.0% | |
| TTM SG&A | -$168.24M | -123.4% | -130.0% | -307.3% | -308.7% | |
| Price | $23.48 | +112.1% | +137.8% | +129.1% | – | |
| Annual Operating Expenses | $1.13B | +34.2% | -9.8% | +89.4% | +51.2% | |
| Annual Operating Profit | -$1.11B | -35.0% | +8.1% | -109.2% | -48.8% | |
| Annual D&A | $7.33M | -30.7% | +23.6% | – | – | |
| Annual Revenue | $29.05M | -11.2% | -47.5% | -57.1% | +1150.1% |
SG&A Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $775.03M | N/A | -100.0% |
| 5Y | $775.03M | -100.0% | |
| All | $775.03M | -100.0% |
SG&A Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $0.00 | N/A | |
| 5Y | $0.00 | N/A | |
| All | $0.00 | N/A |
SG&A History
| Year | Value | Change |
|---|---|---|
| $0.00 | -100.0% | |
| $687.44M | +14.5% | |
| $600.51M | -22.5% | |
| $775.03M | +198.2% |
| Year | Value | Change |
|---|---|---|
| $259.88M | -22.6% | |
| $335.77M | +41.5% | |
| $237.21M | - |
FAQ
What is the current annual SG&A of ROIV?
As of today, ROIV annual SG&A is $0.00
What is 1-year change in ROIV annual SG&A?
ROIV annual SG&A is down -100.00% year-over-year
What is 3-year change in ROIV annual SG&A?
ROIV annual SG&A is down -100.00% over the past 3 years
How far is ROIV annual SG&A from its all-time high?
ROIV annual SG&A is currently -100.00% below its historical high of $775.03M set on March 31, 2022
How does ROIV annual SG&A rank versus sector peers?
ROIV annual SG&A is higher than 39.46% of companies in Healthcare sector
When is ROIV next annual earnings release?
As of today, the next annual earnings release for ROIV has not been scheduled
Quarterly SG&A
$0.00$134.02M-100.00%
Summary
- Current Value
- As of today, ROIV quarterly SG&A is $0.00, down -100.00% on
- Historical Performance
- ROIV quarterly SG&A is down -100.00% year-over-year, and down -100.00% over the past 3 years
- All-Time High Comparison
- ROIV quarterly SG&A is currently -100.00% below its historical high of $437.78M set on
- 3-Year Low Comparison
- ROIV quarterly SG&A vs 3-year low value is unknown
- Sector Comparison
- ROIV quarterly SG&A is higher than 46.07% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly SG&A | $0.00 | -100.0% | -100.0% | -100.0% | -100.0% | |
| Annual SG&A | $0.00 | – | -100.0% | -100.0% | -100.0% | |
| TTM SG&A | -$168.24M | -126.9% | -123.4% | -130.0% | -307.3% | |
| Price | $23.48 | +38.2% | +112.1% | +137.8% | +129.1% | |
| Quarterly Operating Expenses | $306.77M | +7.3% | -11.3% | +5.9% | -44.8% | |
| Quarterly Operating Profit | -$306.23M | -7.5% | +10.4% | -9.1% | +43.4% | |
| Quarterly D&A | $921.00K | -16.1% | +200.2% | -81.8% | – | |
| Quarterly Revenue | $1.57M | -27.6% | -64.9% | -87.5% | -89.6% |
Quarterly SG&A Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $147.09M | -100.0% | |
| 3Y | $202.88M | -100.0% | |
| 5Y | $437.78M | -100.0% | |
| All | $437.78M | -100.0% |
Quarterly SG&A Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $0.00 | N/A | |
| 3Y | $0.00 | N/A | |
| 5Y | $0.00 | N/A | |
| All | $0.00 | N/A |
Quarterly SG&A History
FAQ
What is the current quarterly SG&A of ROIV?
As of today, ROIV quarterly SG&A is $0.00
What is ROIV quarterly SG&A most recent change?
ROIV quarterly SG&A was down -100.00% on September 30, 2025
What is 1-year change in ROIV quarterly SG&A?
ROIV quarterly SG&A is down -100.00% year-over-year
How far is ROIV quarterly SG&A from its all-time high?
ROIV quarterly SG&A is currently -100.00% below its historical high of $437.78M set on September 30, 2021
How does ROIV quarterly SG&A rank versus sector peers?
ROIV quarterly SG&A is higher than 46.07% of companies in Healthcare sector
When is ROIV next earnings release?
The next earnings release for ROIV is on
TTM SG&A
-$168.24M$824.69M-125.63%
Summary
- Current Value
- As of today, ROIV TTM SG&A is -$168.24M, down -125.63% on
- Historical Performance
- ROIV TTM SG&A is down -123.42% year-over-year, and down -129.98% over the past 3 years
- All-Time High Comparison
- ROIV TTM SG&A is currently -107.10% below its historical high of $2.37B set on an earlier date
- 3-Year Low Comparison
- ROIV TTM SG&A is +98.94% above its 3-year low of -$15.95B reached on an earlier date
- Sector Comparison
- ROIV TTM SG&A is higher than 77.92% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM SG&A | -$168.24M | -126.9% | -123.4% | -130.0% | -307.3% | |
| Annual SG&A | $0.00 | – | -100.0% | -100.0% | -100.0% | |
| Quarterly SG&A | $0.00 | -100.0% | -100.0% | -100.0% | -100.0% | |
| Price | $23.48 | +38.2% | +112.1% | +137.8% | +129.1% | |
| TTM Operating Profit | -$1.15B | +3.0% | -17.1% | -22.9% | -112.7% | |
| TTM D&A | $5.39M | +51.9% | -38.9% | -50.3% | – | |
| TTM Revenue | $20.33M | -12.5% | -45.1% | -59.7% | +34.2% |
TTM SG&A Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $2.10B | N/A | -108.0% |
| 3Y | $2.37B | N/A | -107.1% |
| 5Y | $2.37B | N/A | -107.1% |
| All | $2.37B | N/A | -107.1% |
TTM SG&A Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$168.24M | N/A | at low |
| 3Y | -$15.95B | N/A | +98.9% |
| 5Y | -$15.95B | N/A | +98.9% |
| All | -$15.95B | N/A | +98.9% |
TTM SG&A History
FAQ
What is the current TTM SG&A of ROIV?
As of today, ROIV TTM SG&A is -$168.24M
What is ROIV TTM SG&A most recent change?
ROIV TTM SG&A was down -125.63% on September 30, 2025
What is 1-year change in ROIV TTM SG&A?
ROIV TTM SG&A is down -123.42% year-over-year
How does ROIV TTM SG&A rank versus sector peers?
ROIV TTM SG&A is higher than 77.92% of companies in Healthcare sector
When is ROIV next earnings release?
The next earnings release for ROIV is on
Selling, General & Administrative Expenses Formula
SG&A = − − R&D
Data Sources & References
- ROIV Official Website roivant.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1635088/000163508825000016/0001635088-25-000016-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1635088/000114036125020715/0001140361-25-020715-index.htm
- ROIV Profile on Yahoo Finance finance.yahoo.com/quote/ROIV
- ROIV Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/roiv